Project

Blautic has initiated a collaboration with Pfizer Global and Hospital La Fe de Valencia, lasting approximately two years.

This project was launched with the goal of implementing a simple method to monitor the regularity of heartbeats in patients with cardiac TTR amyloidosis (ATTR), in order to improve the early diagnosis of atrial fibrillation (AF) and reduce embolic load.

To achieve this, Blautic has developed Ziven Cardio, a device that will be used by Esther Zorio Grima — a cardiologist at Hospital La Fe and the leader of this research — and her team to draw medical conclusions. The study is entitled: “Improving the Early Detection of Atrial Fibrillation in Cardiac ATTR (AFEDI-cATTR).”

Applications

• Professional and patient access.
• ECG signal capture upon professional request, patient request, or AI pattern detection.
• Posture control, step tracking, physical activity index, and event detection such as fall control.
• Online visualization of signals. Monitoring of usage and device status.

Download the app from Google Play Store

Technical Aspects

Regarding the technical features of the Ziven Cardio device, the following stand out:

• Wireless communications
• ECG sensor
• Accelerometer
• Gyroscope
• Qi wireless charging